Dr, and Associate Prof (Swe Docent), Staffan Folestad is a Director of Science & Innovation in AstraZeneca with global responsibilities in Pharmaceutical Innovation for Materials and Manufacturing Sciences Strategy and External Liaison. He obtained his PhD in Chemistry 1985 from the University of Göteborg and as an Associate Professor he directed academic research activities until 1994 when he joined AstraZeneca (ex Astra Hässle).
Part time he was Adjunct Prof at Uppsala University (from 1999) and is currently affiliated to Chalmers University of Technology. His current research is focused on Patient Centric Pharmaceutical Product and Manufacturing Design, unified solutions for Mass Customization/Mass Personalization, Continuous Manufacturing, in-silicoModeling, and novel in-situSensors for PAT based Control.
He is author of >110 scientific papers, 5 book chapters, and >20 patents. As main or co-supervisor he has trained >20 PhD students and is frequently acting as a referee of peer-review for International Sci Journals. He is an elected member of Royal Swedish Academy of Engineering Sciences (IVA), and initiator of the pan-European science conference series EuPAT. He received the “New Safe Medicines Faster Award 2007” from the European Federation of Pharmaceutical Sciences.